Krisztián Homicskó
Ludwig Cancer Research(CH)
Publications by Year
Research Areas
CAR-T cell therapy research, Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, Cancer Cells and Metastasis, Virus-based gene therapy research
Most-Cited Works
- → The consensus molecular subtypes of colorectal cancer(2015)5,121 cited
- → A colorectal cancer classification system that associates cellular phenotype and responses to therapy(2013)963 cited
- → High-throughput automated organoid culture via stem-cell aggregation in microcavity arrays(2020)375 cited
- → A neutrophil response linked to tumor control in immunotherapy(2023)354 cited
- → MGMT Promoter Methylation Is a Strong Prognostic Biomarker for Benefit from Dose-Intensified Temozolomide Rechallenge in Progressive Glioblastoma: The DIRECTOR Trial(2015)314 cited
- → T cell–induced CSF1 promotes melanoma resistance to PD1 blockade(2018)293 cited
- → Tumor lymphangiogenesis promotes T cell infiltration and potentiates immunotherapy in melanoma(2017)239 cited
- → Late-onset and long-lasting immune-related adverse events from immune checkpoint-inhibitors: An overlooked aspect in immunotherapy(2021)181 cited
- → Sphingolipids control dermal fibroblast heterogeneity(2022)174 cited
- → Phase II Study of Radiotherapy and Temsirolimus versus Radiochemotherapy with Temozolomide in Patients with Newly Diagnosed Glioblastoma without MGMT Promoter Hypermethylation (EORTC 26082)(2016)154 cited